Adaptation to European Spanish and psychometric properties of the Patient Activation Measure 13 in patients with chronic diseases

被引:35
|
作者
Moreno-Chico, Cibeles [1 ,2 ]
Gonzalez-de Paz, Luis [3 ,4 ]
Monforte-Royo, Cristina [1 ]
Arrighi, Emilia [5 ]
Dolores Navarro-Rubio, M. [3 ,5 ]
Gallart Fernandez-Puebla, Alberto [1 ]
机构
[1] Univ Int Catalunya, Dept Nursing, Sch Med & Hlth Sci, C Josep Trueta S-N, Barcelona 08195, Spain
[2] Rambla Mutua Terrassa Primary Healthcare Ctr, Barcelona, Spain
[3] Univ Int Catalunya, Sch Med & Hlth Sci, Publ Hlth & Epidemiol Unit, Barcelona, Spain
[4] IDIBAPS, Transverse Grp Res Primary Care, Consorci Atencio Primaria Esquerra Eixample, Barcelona, Spain
[5] Univ Int Catalunya, Albert J Jovell Inst Publ Hlth & Patients, Barcelona, Spain
关键词
Chronic disease; patient activation; psychometrics; primary health care; translation; Spain; HEALTH OUTCOMES; CARE; VALIDATION; COMMUNICATION; QUALITY; COSTS;
D O I
10.1093/fampra/cmx022
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. The 13-item Patient Activation Measure (PAM-13) is an instrument that assesses people's knowledge, skills and confidence for self-management of their health and health care. Scores on the PAM-13 have been shown to predict adherence to health behaviours, health-related outcomes and health care costs. Objectives. To develop a European Spanish adaptation of the original PAM-13 and to examine its psychometric properties in a sample of chronic patients. Methods. The PAM-13 was forward-backward translated and then completed by chronic patients attending a primary health care centre. Data were analysed with a Rasch model. We assessed the functioning of the rating scale, its reliability, the item goodness-of-fit, differential item functioning (DIF), local dependence, unidimensionality and correlation analysis. Results. A total of 208 patients (80%) completed the questionnaire. Data showed a fit to the Rasch model. More than 50% of patients endorsed all the items. Item rank for the Spanish sample was similar to the original, with few differences. We found significant differences (P < 0.05) in PAM-13 measures according to adherence to prescribed medicines and positive correlations with self-efficacy and physical quality of life. Conclusions. The European Spanish PAM-13 is a reliable and valid instrument for assessing activation in patients with chronic disease in Spain. We suggest adding new items to the instrument so as to examine patients with higher activation levels in the future. Further studies are needed to evaluate the usefulness of this new Spanish PAM-13 in different settings and populations, as well as to examine the relationship between PAM-13 scores and other health-related outcomes.
引用
收藏
页码:627 / 634
页数:8
相关论文
共 50 条
  • [1] Psychometric Properties of the Patient Activation Measure in Family Caregivers of Patients With Chronic Illnesses
    Lin, Chin-Yen
    Chung, Misook L.
    Schuman, Donna L.
    Biddle, Martha J.
    Mudd-Martin, Gia
    Miller, Jennifer L.
    Hammash, Muna
    Schooler, Mary P.
    Rayens, Mary Kay
    Feltner, Frances J.
    Moser, Debra K.
    NURSING RESEARCH, 2023, 72 (04) : 292 - 300
  • [2] Psychometric Properties of the Korean Version of the "Patient Activation Measure 13" (PAM13-K) in Patients With Osteoarthritis
    Ahn, Yang-Heui
    Yi, Chung-Hwi
    Ham, Ok-Kyung
    Kim, Bong-Jeong
    EVALUATION & THE HEALTH PROFESSIONS, 2015, 38 (02) : 255 - 264
  • [3] Psychometric Properties of the Hebrew Translation of the Patient Activation Measure (PAM-13)
    Magnezi, Racheli
    Glasser, Saralee
    PLOS ONE, 2014, 9 (11):
  • [4] Patient activation in Europe: an international comparison of psychometric properties and patients’ scores on the short form Patient Activation Measure (PAM-13)
    Jany Rademakers
    Helle Terkildsen Maindal
    Aslak Steinsbekk
    Jochen Gensichen
    Katja Brenk-Franz
    Michelle Hendriks
    BMC Health Services Research, 16
  • [5] Patient activation in Europe: an international comparison of psychometric properties and patients' scores on the short form Patient Activation Measure (PAM-13)
    Rademakers, Jany
    Maindal, Helle Terkildsen
    Steinsbekk, Aslak
    Gensichen, Jochen
    Brenk-Franz, Katja
    Hendriks, Michelle
    BMC HEALTH SERVICES RESEARCH, 2016, 16 : 1 - 7
  • [6] The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation
    Roesel, Inka
    Froehlich, Daniela
    Joos, Stefanie
    Valentini, Jan
    Mauch, Holger
    Martus, Peter
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2024, 22 (01)
  • [7] Spanish version of the Psychosis Attachment Measure: adaptation process and psychometric properties
    Sheinbaum, Tamara
    Berry, Katherine
    Barrantes-Vidal, Neus
    SALUD MENTAL, 2013, 36 (05) : 403 - 409
  • [8] Psychometric Evaluation of Chronic Patients Using the Persian Version of Patient Activation Measure (PAM)
    Zakeri, Mohammad Ali
    Nadimi, Ali Esmaeili
    Bazmandegan, Golamreza
    Zakeri, Maryam
    Dehghan, Mahlagha
    EVALUATION & THE HEALTH PROFESSIONS, 2023, 46 (02) : 115 - 126
  • [9] Psychometric evaluation of the German version of the patient activation measure (PAM13)
    Jördis M Zill
    Sarah Dwinger
    Levente Kriston
    Anja Rohenkohl
    Martin Härter
    Jörg Dirmaier
    BMC Public Health, 13
  • [10] Psychometric evaluation of the German version of the patient activation measure (PAM13)
    Zill, Joerdis M.
    Dwinger, Sarah
    Kriston, Levente
    Rohenkohl, Anja
    Haerter, Martin
    Dirmaier, Joerg
    BMC PUBLIC HEALTH, 2013, 13